Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Botanix Pharmaceuticals Ltd
BOTCurrent price
0.32 AUD
-0.015 AUD (-4.48%)
Last closed
0.32 AUD
Company
www.botanixpharma.com
ISIN
AU000000BOT2
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
590 435 054 AUD
Yield for 12 month
+120.69 %
1Y
3Y
5Y
10Y
15Y
BOT
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia and the United States. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in West Perth, Australia. Address: 41 ? 47 Colin Street, West Perth, WA, Australia, 6005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 AUDP/E ratio
–Dividend Yield
–Current Year
+610 976 AUD
Last Year
+928 893 AUD
Current Quarter
+1 717 291 AUD
Last Quarter
+383 679 AUD
Current Year
-3 096 784 AUD
Last Year
-3 092 270 AUD
Current Quarter
-997 378 AUD
Last Quarter
-3 070 982 AUD
Key Figures BOT
1 year
3 years
5 years
10 years
EBITDA
-14 131 131 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.74 %
PEG Ratio
–
Return On Equity TTM
-21.07 %
Wall Street Target Price
1 AUD
Revenue TTM
2 100 971 AUD
Book Value
0.061 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2753.2 %
Dividend Yield
–
Gross Profit TTM
-1 984 869 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BOT
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
–Dividend History BOT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:3
Payout Ratio
–
Last Split Date
16.06.2016
Dividend Date
–
Stock Valuation BOT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
997.2515
Price Sales TTM
281.0296
Enterprise Value EBITDA
-11.0772
Price Book MRQ
5.5995
Financials BOT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BOT
For 52 weeks
0.14 AUD
0.45 AUD
50 Day MA
0.38 AUD
Shares Short Prior Month
–
200 Day MA
0.3 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart